Resmed Inc Drc Stock Z Score
RSMDFDelisted Stock | USD 17.70 0.00 0.00% |
Resmed |
Resmed Inc DRC Company Z Score Analysis
Resmed's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionBased on the company's disclosures, Resmed Inc DRC has a Z Score of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Instruments & Supplies industry. The z score for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
All Next | Launch Module |
Resmed Fundamentals
Return On Equity | 0.24 | |||
Return On Asset | 0.12 | |||
Profit Margin | 0.22 % | |||
Operating Margin | 0.28 % | |||
Current Valuation | 33.08 B | |||
Shares Outstanding | 1.47 B | |||
Shares Owned By Institutions | 7.93 % | |||
Price To Earning | 28.58 X | |||
Price To Book | 9.54 X | |||
Price To Sales | 9.04 X | |||
Revenue | 3.58 B | |||
Gross Profit | 2.06 B | |||
EBITDA | 1.18 B | |||
Net Income | 779.44 M | |||
Cash And Equivalents | 273.71 M | |||
Cash Per Share | 0.47 X | |||
Total Debt | 765.33 M | |||
Debt To Equity | 0.27 % | |||
Current Ratio | 2.80 X | |||
Book Value Per Share | 6.36 X | |||
Cash Flow From Operations | 351.15 M | |||
Earnings Per Share | 0.55 X | |||
Price To Earnings To Growth | 1.76 X | |||
Target Price | 11.49 | |||
Number Of Employees | 8.16 K | |||
Beta | 0.47 | |||
Market Capitalization | 34.16 B | |||
Total Asset | 5.1 M | |||
Annual Yield | 0.01 % | |||
Net Asset | 5.1 M | |||
Last Dividend Paid | 1.72 |
About Resmed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Resmed Inc DRC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Resmed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Resmed Inc DRC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Resmed Pink Sheet
If you are still planning to invest in Resmed Inc DRC check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Resmed's history and understand the potential risks before investing.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
CEOs Directory Screen CEOs from public companies around the world | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |